Other
Drug Facts
Dist. by: Reckitt Benckiser
Parsippany, NJ 07054-0224
Made in England
The following Structured Product Label (SPL) was submitted to the FDA by Reckitt Benckiser Llc for the product Mucinex D (NDC 63824-041). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, otc - purpose, uses, otc - do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, otc - pregnancy or breast feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Dist. by: Reckitt Benckiser
Parsippany, NJ 07054-0224
Made in England
| Active ingredients (in each extended-release bi-layer tablet) | Purposes |
|---|---|
| Guaifenesin 1200 mg | Expectorant |
| Pseudoephedrine HCl 120 mg | Nasal Decongestant |
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
carbomer homopolymer type B; FD&C yellow #6 aluminum lake; hypromellose, USP; magnesium stearate, NF; microcrystalline cellulose, NF; sodium starch glycolate, NF
1-866-MUCINEX (1-866-682-4639)
You may also report side effects to this phone number.
MAXIMUM STRENGTH
NDC 63824-041-24
Mucinex® D
1200 mg guaifenesin & 120 mg pseudoephedrine HCl
extended-release bi-layer tablets
EXPECTORANT
& NASAL DECONGESTANT
12
HOUR
24 EXTENDED-RELEASE
BI-LAYER TABLETS
* Please review the disclaimer below.